NCT07707531RecruitingEarly phase 1
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
This study is to evaluate the safety, biodistribution, radiation dosimetry and tumor uptake of the \[68Ga\]/ \[131I\]-IR199 in patients with Claudin 18.2 positive gastric cancer and pancreatic cancer.
- Status (registry)
- Recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 29 Jun 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Huashan Hospital
- NCT number
- NCT07707531
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 10
- From 1 Jun 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known or suspected history of ≥3 grade renal and urinary system diseases.
- Medical history of allergy, hypersensitivity reaction or intolerance to radioactive drugs.
Other
- Less than two weeks since the last treatment that could cause bone marrow suppression.
Who the study is looking for
- Informed consent must be obtained in writing from the subject, their legally authorized representative, or caregiver.
- Age equal to or above 18 years old.
- Histologically or cytologically confirmed gastric cancer or pancreatic cancer with Claudin 18.2 expression.
- Must have ≥1 Claudin 18.2 positive lesions.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huashan Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.